Clinical trial
Open-Label Phase 3 Study to Evaluate the Long-Term Safety and Efficacy of Udenafil Tablets in Male Subjects With Erectile Dysfunction
NCT01065012 is registered in ClinicalTrials.gov with Warner Chilcott as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Open-Label Phase 3 Study to Evaluate the Long-Term Safety and Efficacy of Udenafil Tablets in Male Subjects With Erectile Dysfunction
- Lead sponsor
- Warner Chilcott
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 31, 2010
- Completion date
- February 28, 2011
- Enrollment
- 1,027 (actual)
- Sites
- 72
Conditions
As the registry lists them; a condition with its own page is linked.